Preferred Label : Hypobetalipoproteinemia, familial, 1;
Symbol : FHBL1;
CISMeF acronym : FHBL; FHBL1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Acanthocytosis with hypobetalipoproteinemia; Hypobetalipoproteinemia, familial; Hypobetalipoproteinemia, normotriglyceridemic; FHBL;
Included titles and symbols : LDLCQ4; Low density lipoprotein cholesterol level quantitative trait locus 4;
Description : Hypobetalipoproteinemia (FBHL) and abetalipoproteinemia (ABL; 200100) are rare diseases
characterized by hypocholesterolemia and malabsorption of lipid-soluble vitamins leading
to retinal degeneration, neuropathy, and coagulopathy. Hepatic steatosis is also common.
The root cause of both disorders is improper packaging and secretion of apolipoprotein
B-containing particles. Obligate heterozygous parents of FBHL patients typically have
half normal levels of apoB-containing lipoproteins consistent with autosomal codominant
inheritance, whereas obligate heterozygous parents of ABL patients usually have normal
lipids consistent with autosomal recessive inheritance (summary by Lee and Hegele,
2013). - Genetic Heterogeneity of Familial Hypobetalipoproteinemia Familial hypobetalipoproteinemia-2
(FHBL2; 605019) is caused by mutation in the ANGPTL3 gene (604774) on chromosome 1p31.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the apolipoprotein B gene (APOB, 107730.0001);
Laboratory abnormalities : Hypobetalipoproteinemia; Decreased serum cholesterol;
Prefixed ID : #615558;
Origin ID : 615558;
UMLS CUI : C4551990;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT